NSE: INDGN | BSE: 544172

Download real time

579.35 5.25 (0.91%)

193.5K NSE+BSE Volume

NSE 23 Apr, 2025 1:06 PM (IST)

13,862

Market Cap

High in industry

Beta 1Year

Board Meeting

The next board meeting for Indegene Ltd. is on 28 Apr 2025 for the purpose of Audited Results & Final Dividend See details

Indegene Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for INDGN, BSE:544172 Indegene Ltd.

Search Inside the pdf :

Indegene Ltd.

10 Jul 2024

579.35

0.91%

Indegene Limited - Revolutionizing Life Sciences' Marketing Way

Buy: Indegene Ltd.

Monarch Networth Capital Limited

Number of FII/FPI investors increased from 102 to 114 in Mar 2025 qtr.

Indegene Ltd.

06 May 2024

579.35

0.91%

IPO Note

IPO Subscribe: Indegene Ltd.

KRChoksey

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. The Company has established client relationships with each of the 20 largest biopharmaceutical companies in the world.

Indegene Ltd. has an average target of 660.00 from 7 brokers.

Indegene Ltd.

03 May 2024

579.35

0.91%

IPO Note - Indegene Limited 06052024

IPO Note: Indegene Ltd.

HDFC Securities

IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products